Your privacy is very important to us. When you visit our website, please agree to the use of all cookies. For more information about personal data processing, please go to Privacy Policy.
2025
2024
2023
2022
2021
2020
2019
-
May 19,2023
NSR｜HuidaGene's Yang Hui team pioneers disruptive guanine (G) base editor
Learn More
-
May 03,2023
Huidagene Therapeutics Announces 19 Presentations Highlighting Advances in its Gene Therapy Technology Platforms at the 2023 ASGCT Annual Meeting
Learn More
-
Apr 18,2023
HuidaGene Announces IND Approval Of The First China Multinational Master Protocol of HG004 By China NMPA
Learn More
-
Apr 10,2023
HuidaGene Appoints New Members to the Scientific Advisory Board
Learn More
-
Feb 14,2023
Statement: English name changed from "HuiGene Therapeutics Co., Ltd." to "HuidaGene Therapeutics Co., Ltd.e "
Learn More
-
Feb 14,2023
HuidaGene Announces Completion of First Patient Enrollment in its Ophthalmic Gene Therapy Candidate HG004 IIT Clinical Trials
Learn More
-
Jan 28,2023
HuidaGene Therapeutics Announces IND Active for the Multinational Trial of HG004 to Treat Inherited Blindness
Learn More
-
Jan 10,2023
Engineered high-fidelity Cas13 variants with minimal collateral RNA targeting
Learn More
-
Dec 21,2022
HuidaGene team of scientists collaborate to discover potential new treatment for Duchenne muscular dystrophy
Learn More